Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

219
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
219
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

153
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
153
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

313
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
313
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

463
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
463
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

986
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
986
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

636
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
636

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term classification stability and treatment patterns of inflammatory bowel disease unclassified: a longitudinal observational study.

BMJ open gastroenterology·2026
Same author

Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease-A Core Phenotype Beyond Inflammatory Activity. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

IDEA-FAST clinical study protocol: Identifying digital end-points of fatigue, sleep quality and daytime sleepiness in N = 2000.

Digital health·2026
Same author

Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty?

Alimentary pharmacology & therapeutics·2026
Same author

Comparative analysis of inflammatory bowel disease (IBD) patient- and service-reported quality of care using 2019 and 2023 UK benchmarking data from more than 26 000 adult patient respondents and 154 IBD services.

Journal of Crohn's & colitis·2026
Same author

Psychological Resilience and Mental Wellbeing Mitigate the Risk of Irritable Bowel Syndrome.

The American journal of gastroenterology·2026

Related Experiment Video

Updated: Sep 30, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K

Risk stratifying gastric ulcers: development and validation of a scoring system.

William M Brindle1, Rebecca K Grant1, Marianne Smith1

  • 1The Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.

Frontline Gastroenterology
|March 17, 2022
PubMed
Summary
This summary is machine-generated.

Routine endoscopic follow-up for gastric ulcers may not be necessary for all patients. A new risk score can identify low-risk cases, avoiding unnecessary procedures and focusing on high-risk individuals for early cancer detection.

Keywords:
gastric and duodenal ulcersgastrointesinal endoscopygastrointestinal cancer

More Related Videos

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

3.4K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.7K

Related Experiment Videos

Last Updated: Sep 30, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.2K
Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

3.4K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.7K

Area of Science:

  • Gastroenterology
  • Oncology
  • Medical Diagnostics

Background:

  • The necessity of routine endoscopic follow-up for gastric ulcer healing remains debated.
  • Accurate risk stratification is crucial for optimizing patient management and resource allocation.

Purpose of the Study:

  • To evaluate the utility of follow-up oesophago-gastro-duodenoscopies (OGDs) for gastric ulcer healing.
  • To develop and validate a risk score for stratifying patients based on malignancy risk.

Main Methods:

  • Retrospective analysis of patients diagnosed with gastric ulcers undergoing index OGDs.
  • Logistic regression was used to identify factors associated with malignancy and derive a risk score.
  • External validation of the derived risk score was performed.

Main Results:

  • Older age, larger ulcer size, and non-antral location were significantly associated with malignancy.
  • The derived risk score demonstrated high accuracy (AUC 0.868, validated AUC 0.862) in distinguishing between benign and malignant ulcers.
  • A low risk score combined with benign ulcer appearance and negative biopsies showed a high negative predictive value (NPV 97.4%, validated NPV 98.6%) for malignancy.

Conclusions:

  • Patients with macroscopically benign gastric ulcers, negative biopsies, and a low-risk score may not require routine endoscopic follow-up.
  • The developed risk score aids in identifying patients who can safely forgo follow-up OGDs, thereby improving efficiency in gastric ulcer management.